METAFORA and collaborators publishes a paper in Annals of Neurology
June 19, 2017METAFORA receives exceptional reimbursement for its new blood test METAglut1
April 11, 2018On July 13 and 14, the biannual conference of the American Association GLUT1 Deficiency Foundation is held in Nashville. This conference is probably the biggest event dedicated to the disease on a global scale, and brings together a large number of patient families, of course, but also doctors and other health professionals.
METAFORA will participate by presenting its new METAglut1 test, developed to detect GLUT1DS syndrome early with a simple blood test. The company will hold a stand and will have the honor of also making an oral communication.
–
Alongside Magali SORRET, President of the Association on Glut1 Deficiency Syndrome, Metafora is pleased to announce a partnership between Metafora Biosystems and this association created by parents of children suffering from this condition. The Association on Glut1 Deficit Syndrome has the ambition to make known and recognize the disease among health professionals, thus facilitating early detection and accompanying, supporting families in their daily lives. From this moving meeting with the Collective Solhand was born a partnership with Metafora. Great support for us to carry out very beautiful actions. Nashville should bring us a lot to help our patients in France.